GILD

Gilead Sciences Inc (GILD) Stock Price

Closed
GILD
$165.86
-$0.51(-0.30%)

Content updated: 2026-11-22 21:59:51

Yesterday's Close
$166.37
Today's Open
$168.69
Today's High
$169.97
Today's Low
$165.63
Volume
8.87M shares
52-Week Range
$122.41-$176.91

As of 2026-11-22 21:59:51, Gilead Sciences Inc (GILD) was quoted at $165.86, a change of -$0.51 (-0.30%) from the previous close. The day's range was $165.63–$169.97, and the 52-week range was $122.41–$176.91.

Why Is Gilead Sciences Inc (GILD) Stock Falling?

AI Stock Price Analysis

Content updated: 2026-11-20 20:50:07

GILD fell 1.44% from a prior close of $168.96 to $166.53 and weakened steadily after opening at $169.16, finishing below its volume-weighted average price (VWAP) of $166.95. The clearest recent company news was expanded voluntary licensing for investigational Ebola drug Obeldesivir, yet full-day volume ran at only 0.60 of baseline, leaving the decline without volume confirmation.

Past 1W-2.67%Period Low $164.79Period High $171.69
Past 1M+7.92%Period Low $153.14Period High $176.58
Past 3M+13.57%Period Low $142.60Period High $176.58
Past 1Y+32.80%Period Low $116.88Period High $176.58

About Gilead Sciences Inc (GILD)

Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.
Ticker / Exchanges
GILD / NASDAQ
Industry / Sector
Drug Manufacturers - General / Healthcare
CEO
Daniel O'Day
Headquarters
Foster City,CA,US
Official Website
https://www.gilead.com
Listing Date
1992-01-22

Recent Company Events

  • 2027-02-09
    Earnings Report · ExpectedOn 2027-02-09, the 2026/Q4 earnings report is expected to be released.

Gilead Sciences Inc (GILD) Derivatives Trading

GILDTrade
Stocks

Trade U.S., Hong Kong, Japanese, and South Korean stocks directly. Selected U.S., Hong Kong, and South Korean stocks support 24/7 trading. You hold actual shares. Corporate actions such as dividends and stock splits are handled according to market rules.

GILDTrade
CFD

Trade stock price movements through CFDs without holding the underlying shares. CFDs support long and short positions and leveraged trading. Be aware of spreads, trading fees, overnight fees, and liquidation risk.

GILDUSDTTrade
Perpetual Futures

Contracts based on stock prices, with no expiration date. They support 24/7 long, short, and leveraged trading without holding the underlying shares. Be aware of funding fees and liquidation risk.

Gilead Sciences Inc (GILD) Company Financials

Valuation and Shares

Market Cap
$206.46B
P/E Ratio (TTM)
-53.17
P/B Ratio
15.83
Shares Outstanding
1.24B shares
Float Shares
1.23B shares
Dividend Yield (TTM)
1.95%

Latest Reported Financials

2026 Q3 Financials

Report Release Date: 2026-10-29

Operating Revenue (Actual)

$8.30B

Same Period Last Year: +6.83%

Earnings per Share (Actual)

$2.55

Same Period Last Year: +3.24%

Financials · Actuals

Actual Value2022/Annual2023/Annual2024/Annual2025/Annual
Revenue$27.28B$27.11B$28.75B$29.44B
Net Profit$4.59B$5.66B$480.00M$8.51B
Operating Cash Flow$9.07B$8.00B$10.82B$10.01B

GILD FAQ

What is the current stock price of Gilead Sciences Inc (GILD)?

x
As of 2026-11-22 21:59 (UTC+8), the latest available quote for Gilead Sciences Inc (GILD) is $165.86 USD, with a change of -$0.51 USD (-0.30%) from the previous trading day's close. Current market status: Closed.

Which exchange is GILD listed on?

x

How has Gilead Sciences Inc stock performed over the past month?

x

What is the market cap of Gilead Sciences Inc?

x

What are Gilead Sciences Inc's latest financial results?

x

What factors may affect the stock price of Gilead Sciences Inc (GILD)?

x

Other Trading Markets

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.